Articles

Market Snapshot: S&P 500 futures slip ahead of Fed decision and Treasury funding announcement

After October delivered a third consecutive month of declines for the S&P 500, November is starting on a similarly cautious note

NerdWallet: Check with your electric company for these EV incentives you may not know about

EV incentives offered through local electric companies can range from hundreds to thousands of dollars toward the purchase or lease of an EV.

Kelley Blue Book: Why buy thrills when you can rent them? These are the most popular cars on Turo.

If you've ever wanted to try a Corvette or a Jeep, you can find everything from exotic cars to classic sports cars to the latest EVs available for rent.

NerdWallet: Don’t shy away from getting a second opinion—it could save your life

The harsh reality is that misdiagnosis happens a lot — and sometimes with deadly consequences. Getting a medical second opinion could save your life.

NerdWallet: Paycheck advance apps: the risks—and costs—can be high

As inflation keeps everyday costs like groceries high, consumer advocates and financial experts warn against relying on services that promise fast cash advances

Earnings Results: Yum China just gave investors a new reason to worry about the Chinese economy

Yum China said it saw 'softening' demand for its fast food starting in late September.

Dow Jones Newswires: China’s Caixin manufacturing PMI falls into contraction in October

A private gauge of China's factory activity fell into contraction in October, signaling continued economic headwinds despite Beijing's recent efforts to shore up growth.

Dow Jones Newswires: South Korea’s exports rise in October after a year of declines

South Korea's October exports rose for the first time, after falling for a year, on brisk demand for transport, machinery and other goods, the latest sign of a recovery in global demand.

MarketWatch First Take: AMD makes bold prediction for its AI chips — but it’s actually not so far-fetched

AMD's bold AI outlook may look like a high hurdle, but it's quite feasible that CEO Lisa Su can deliver on her promise.

Dow Jones Newswires: Tonix shares sink 29% on discontinued development on depression treatment

Shares of Tonix Pharmaceuticals fell Tuesday after the company said it would discontinue development of its treatment for major depressive disorder.

Dow Jones Newswires: Amgen gets FDA approval for its inflammatory diseases treatment Wezlana

Amgen has received approval from the U.S. Food and Drug Administration for Wezlana, its treatment for multiple inflammatory diseases.

The Ratings Game: Here’s why Zillow, Redfin and other real-estate stocks tanked after a jury ruling

Shares of real-estate names plunged Tuesday following a jury ruling that has the potential to shake up the way people purchase homes.
1 1,983 1,984 1,985 1,986 1,987 2,495